Controlled reperfusion versus conventional treatment of the acutely ischemic limb: results of a randomized, open-label, multicenter trial
C Heilmann, C Schmoor, M Siepe… - Circulation …, 2013 - Am Heart Assoc
Background—Amputation rates and mortality in patients with severe acute limb ischemia
remain high. The protective effect of controlled reperfusion (CR) on tissue damage because …
remain high. The protective effect of controlled reperfusion (CR) on tissue damage because …
Controlled reperfusion versus conventional treatment of the acutely ischemic limb: results of a randomized, open-label, multicenter trial.
C Heilmann, C Schmoor, M Siepe… - Circulation …, 2013 - europepmc.org
Background Amputation rates and mortality in patients with severe acute limb ischemia
remain high. The protective effect of controlled reperfusion (CR) on tissue damage because …
remain high. The protective effect of controlled reperfusion (CR) on tissue damage because …
Peripheral Artery Disease
C Heilmann, C Schmoor, M Siepe, C Schlensak, A Hoh… - 2013 - Am Heart Assoc
Study Design The CRAIL trial was designed as a prospective, randomized, openlabel,
multicenter superiority trial to compare efficacy and safety of conventional treatment (CT) …
multicenter superiority trial to compare efficacy and safety of conventional treatment (CT) …
Controlled reperfusion versus conventional treatment of the acutely ischemic limb: results of a randomized, open-label, multicenter trial
C Heilmann, C Schmoor, M Siepe, C Schlensak, A Hoh… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Amputation rates and mortality in patients with severe acute limb ischemia
remain high. The protective effect of controlled reperfusion (CR) on tissue damage because …
remain high. The protective effect of controlled reperfusion (CR) on tissue damage because …